Insider Trading & Ownership - Schwab Andrew J.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Schwab Andrew J.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-02-14
Sale
2024-02-16
4:15 pm
Enliven Therapeutics Inc.ELVN5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
PARMAR KUSH
Schwab Andrew J.
10% Owner
825,000$14.9$12,292,500635,341
(Indirect)
View
2024-01-31
Sale
2024-02-02
4:29 pm
Enliven Therapeutics Inc.ELVN5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
PARMAR KUSH
Schwab Andrew J.
10% Owner
500,000$15$7,500,000771,983
(Indirect)
View
2023-09-26
Sale
2023-09-28
4:27 pm
Enliven Therapeutics Inc.ELVN5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
PARMAR KUSH
Schwab Andrew J.
10% Owner
197,500$15$2,962,500854,796
(Indirect)
View
2023-08-24
Sale
2023-08-28
4:20 pm
Enliven Therapeutics Inc.ELVN5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
PARMAR KUSH
Schwab Andrew J.
10% Owner
440,000$16$7,040,000887,507
(Indirect)
View
2023-04-10
Sale
2023-04-12
4:51 pm
Pear Therapeutics Inc.PEAR5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
16,544,113$0.12$1,985,294200,000
(Indirect)
View
2023-03-07
Sale
2023-03-09
4:35 pm
Rallybio CorpRLYB5AM Partners V LLC
Schwab Andrew J.
5AM Ventures V L.P.
ROCKLAGE SCOTT M
10% Owner
100,000$8.2$820,0003,630,724
(Indirect)
View
2022-11-11
Sale
2022-11-15
8:32 pm
Pear Therapeutics Inc.PEAR5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
105,281$2.7381$288,2673,907,624
(Indirect)
View
2022-10-31
Sale
2022-11-02
7:49 pm
Pear Therapeutics Inc.PEAR5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
54,209$2.7688$150,0963,911,835
(Indirect)
View
2022-10-06
Sale
2022-10-11
7:10 pm
scPharmaceuticals Inc.SCPH5AM Partners IV LLC
5AM Co-Investors IV L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
5AM Ventures IV L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
600,000$4.1482$2,488,907410,268
(Indirect)
View
2022-09-14
Sale
2022-09-16
6:03 pm
Pear Therapeutics Inc.PEAR5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
558,168$1.8764$1,047,3223,914,004
(Indirect)
View
2022-09-06
Sale
2022-09-08
8:01 pm
Pear Therapeutics Inc.PEAR5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
770,000$2.0543$1,581,8353,936,331
(Indirect)
View
2022-09-06
Sale
2022-09-08
7:58 pm
scPharmaceuticals Inc.SCPH5AM Partners IV LLC
5AM Co-Investors IV L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
5AM Ventures IV L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
226,622$4.8405$1,096,953503,112
(Indirect)
View
2022-08-16
Sale
2022-08-18
8:05 pm
Pear Therapeutics Inc.PEAR5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
400,000$1.6501$660,0603,967,131
(Indirect)
View
2022-08-15
Purchase
2022-08-17
8:01 pm
CinCor Pharma Inc.CINC5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
Schwab Andrew J.
PARMAR KUSH
5AM Opportunities II (GP) LLC
5AM Opportunities II L.P.
10% Owner
600,000$30$18,000,000983,656
(Indirect)
View
2022-06-03
Sale
2022-06-07
5:02 pm
Rallybio CorpRLYB5AM Opportunities I L.P.
Schwab Andrew J.
5AM Opportunities I (GP) LLC
5AM Partners V LLC
5AM Ventures V L.P.
ROCKLAGE SCOTT M
10% Owner
150,000$12.5$1,875,0002,478,969
(Indirect)
View
2022-05-23
Sale
2022-05-25
6:31 pm
Rallybio CorpRLYB5AM Opportunities I L.P.
Schwab Andrew J.
5AM Opportunities I (GP) LLC
5AM Partners V LLC
5AM Ventures V L.P.
ROCKLAGE SCOTT M
10% Owner
100,000$13$1,300,0002,578,640
(Indirect)
View
2022-04-11
Sale
2022-04-13
4:51 pm
scPharmaceuticals Inc.SCPH5AM Partners IV LLC
5AM Co-Investors IV L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
5AM Ventures IV L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
270,000$5$1,350,000537,301
(Indirect)
View
2022-02-08
Sale
2022-02-10
6:24 pm
Rallybio CorpRLYB5AM Opportunities I L.P.
Schwab Andrew J.
5AM Opportunities I (GP) LLC
5AM Partners V LLC
5AM Ventures V L.P.
ROCKLAGE SCOTT M
10% Owner
210,000$13.05$2,740,5002,645,087
(Indirect)
View
2022-01-11
Purchase
2022-01-13
4:45 pm
CinCor Pharma Inc.CINC5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
Schwab Andrew J.
PARMAR KUSH
10% Owner
470,000$16$7,520,000496,323
(Indirect)
View
2021-11-16
Sale
2021-11-18
8:14 pm
Vor Biopharma Inc.VOR5AM Ventures VI L.P.
5AM Partners VI LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
Schwab Andrew J.
10% Owner
330,706$15.3$5,059,8021,766,634
(Indirect)
View
2021-11-02
Purchase
2021-11-04
9:10 pm
Entrada Therapeutics Inc.TRDA5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
250,000$20$5,000,0001,132,357
(Indirect)
View
2021-11-01
Sale
2021-11-03
4:38 pm
Cabaletta Bio Inc.CABA5AM Ventures V L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
295,000$13$3,835,000333,144
(Indirect)
View
2021-09-07
Sale
2021-09-09
5:34 pm
Cabaletta Bio Inc.CABA5AM Ventures V L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
625,000$9.7$6,062,5002,359,263
(Indirect)
View
2021-08-02
Purchase
2021-08-04
9:17 pm
Rallybio CorpRLYB5AM Opportunities I L.P.
Schwab Andrew J.
5AM Opportunities I (GP) LLC
5AM Partners V LLC
5AM Ventures V L.P.
ROCKLAGE SCOTT M
10% Owner
615,384$13$7,999,9924,190,724
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-13
Option Award
2024-03-15
4:15 pm
N/A
N/A
Skye Bioscience Inc.SKYESchwab Andrew J.
Director
10% Owner
450,000$1010,179,505
(Indirect)
View
2024-02-29
Option Award
2024-03-04
4:04 pm
N/A
2034-03-01
Skye Bioscience Inc.SKYESchwab Andrew J.
Director
35,000$035,000
(Direct)
View
2024-01-31
Option Award
2024-02-02
4:35 pm
N/A
N/A
Skye Bioscience Inc.SKYESchwab Andrew J.
Director
10% Owner
5,206,074$2.319,729,505
(Indirect)
View
2023-11-06
Option Award
2023-11-06
8:29 pm
N/A
2033-08-25
Skye Bioscience Inc.SKYESchwab Andrew J.
Director
14,110$020,001
(Direct)
View
2023-08-25
Option Award
2023-08-29
9:36 pm
N/A
2033-08-25
Skye Bioscience Inc.SKYESchwab Andrew J.
Director
1,472,692$01,472,692
(Direct)
View
2023-08-18
Option Award
2023-08-22
5:21 pm
N/A
N/A
Skye Bioscience Inc.SKYESchwab Andrew J.
Director
10% Owner
852,696,240$0.0103443,296,919
(Indirect)
View
2023-08-18
Option Award
2023-08-22
5:21 pm
2023-08-18
2033-08-18
Skye Bioscience Inc.SKYESchwab Andrew J.
Director
10% Owner
704,509,037$0443,296,919
(Indirect)
View
2023-02-23
Option Award
2023-04-06
8:22 pm
N/A
2033-02-23
Enliven Therapeutics Inc.ELVNSchwab Andrew J.
Director
10% Owner
27,567$027,567
(Direct)
View
2023-02-24
Equity Swap
2023-02-28
4:29 pm
N/A
N/A
CinCor Pharma Inc.CINC5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I L.P.
Schwab Andrew J.
PARMAR KUSH
5AM Opportunities II (GP) LLC
5AM Opportunities II L.P.
5AM Opportunities I (GP) LLC
10% Owner
4,937,646$00
(Indirect)
View
2023-02-23
Option Award
2023-02-27
9:55 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNSchwab Andrew J.
Director
5,798,475$0960,383
(Indirect)
View
2022-11-30
Equity Swap
2022-12-02
3:38 pm
N/A
N/A
Akouos Inc.AKUS5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
4,135,786$00
(Indirect)
View
2022-01-11
Conversion
2022-01-13
4:45 pm
N/A
N/A
CinCor Pharma Inc.CINC5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
Schwab Andrew J.
PARMAR KUSH
10% Owner
17,017,645$0496,323
(Indirect)
View

Ownership
2022-01-06
9:02 pm
N/A
N/A
CinCor Pharma Inc.CINC5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
Schwab Andrew J.
PARMAR KUSH
10% Owner
0$03,867,646
(Indirect)
View
2021-12-03
Option Award
2021-12-07
5:25 pm
N/A
N/A
Pear Therapeutics Inc.PEARSchwab Andrew J.
Director
10% Owner
18,431,771$03,372,769
(Indirect)
View
2021-12-03
Option Award
2021-12-07
5:25 pm
N/A
N/A
Pear Therapeutics Inc.PEARSchwab Andrew J.
Director
10% Owner
200,000$103,372,769
(Indirect)
View
2021-11-02
Conversion
2021-11-04
9:10 pm
N/A
N/A
Entrada Therapeutics Inc.TRDA5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
31,520,600$01,132,357
(Indirect)
View

Ownership
2021-10-28
9:30 pm
N/A
N/A
Entrada Therapeutics Inc.TRDA5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
0$04,158,379
(Indirect)
View
Goto 0, 1, Next